共有 50 笔近期内部人交易记录记录，涉及 Talis Biomedical Corporation (TLIS), 包括 37 笔买入 和 5 笔卖出. 内部人买入总额为 $12.33M 内部人卖出总额为 $47.41K.
近期活跃的重要内部人包括 Leonard Braden Michael, Young John T. Jr., Ferrari Patricia. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TLIS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-09-06 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
25,000 |
$1.48 |
$37.1K |
248,702 |
| 2024-09-05 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
5,100 |
$1.40 |
$7.14K |
223,702 |
| 2024-09-03 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
500 |
$4.00 |
$2K |
218,602 |
| 2024-08-30 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
151 |
$4.25 |
$641.75 |
218,602 |
| 2024-08-28 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
1,215 |
$3.96 |
$4.81K |
217,951 |
| 2024-08-26 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
13,167 |
$3.90 |
$51.32K |
216,736 |
| 2024-08-14 |
Leonard Braden Michael |
10 Percent Owner |
未知 |
- |
- |
- |
203,569 |
| 2024-07-31 |
Young John T. Jr. |
Director |
未知 |
- |
- |
- |
- |
| 2024-07-31 |
Ferrari Patricia |
Director |
未知 |
- |
- |
- |
- |
| 2023-08-01 |
Lukowiak Andrew A |
Officer |
未知 |
- |
- |
- |
- |
| 2023-08-01 |
Lukowiak Andrew A |
President |
限制性股票授予 (RSU) |
30,575 |
$7.42 |
$226.87K |
30,575 |
| 2023-07-17 |
Markovich Rebecca |
Interim CFO |
限制性股票授予 (RSU) |
13,071 |
$7.65 |
$99.99K |
13,071 |
| 2023-06-09 |
Popovits Kimberly J |
Director |
限制性股票授予 (RSU) |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Scott Randal W. |
Director |
限制性股票授予 (RSU) |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Dreismann Heinrich |
Director |
限制性股票授予 (RSU) |
5,466 |
$0.50 |
$2.73K |
5,466 |
| 2023-06-09 |
Posard Matthew L. |
Director |
限制性股票授予 (RSU) |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Ismagilov Rustem F. |
Director |
限制性股票授予 (RSU) |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Gilliam Melissa |
Director |
限制性股票授予 (RSU) |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Baker Bros. Advisors Lp |
10 Percent Owner |
限制性股票授予 (RSU) |
23,685 |
$0.50 |
$11.95K |
23,685 |
| 2023-05-19 |
Dreismann Heinrich |
Director |
未知 |
- |
- |
- |
- |
| 2023-05-19 |
Dreismann Heinrich |
Director |
限制性股票授予 (RSU) |
190,000 |
$0.46 |
$87.4K |
190,000 |
| 2023-04-21 |
Markovich Rebecca |
Interim CFO |
处置 |
70,000 |
$0.49 |
$34.3K |
- |
| 2023-04-07 |
Moody John Roger Jr |
Chief Financial Officer |
限制性股票授予 (RSU) |
300,000 |
$0.49 |
$147K |
300,000 |
| 2023-04-07 |
Kelley Robert J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
500,000 |
$0.49 |
$245K |
500,000 |
| 2023-03-10 |
Cheong Raymond |
Director |
未知 |
- |
- |
- |
- |
| 2022-06-10 |
Baker Bros. Advisors Lp |
10 Percent Owner |
限制性股票授予 (RSU) |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Popovits Kimberly J |
Director |
限制性股票授予 (RSU) |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Scott Randal W. |
Director |
限制性股票授予 (RSU) |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Baker Brothers Life Sciences Lp |
Director |
限制性股票授予 (RSU) |
95,000 |
- |
- |
95,000 |
| 2022-06-10 |
Posard Matthew L. |
Director |
限制性股票授予 (RSU) |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Ismagilov Rustem F. |
Director |
限制性股票授予 (RSU) |
95,000 |
- |
- |
95,000 |
| 2022-06-10 |
Gilliam Melissa |
Director |
限制性股票授予 (RSU) |
95,000 |
- |
- |
95,000 |
| 2022-06-01 |
Moody John Roger Jr |
Chief Financial Officer |
限制性股票授予 (RSU) |
500,000 |
- |
- |
500,000 |
| 2022-06-01 |
Kelley Robert J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
723,560 |
- |
- |
723,560 |
| 2021-12-08 |
Kelley Robert J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
450,000 |
$4.28 |
$1.93M |
450,000 |
| 2021-12-01 |
Blaser Brian J |
President and CEO |
未知 |
- |
- |
- |
- |
| 2021-12-01 |
Blaser Brian J |
President and CEO |
限制性股票授予 (RSU) |
625,000 |
- |
- |
625,000 |
| 2021-11-18 |
Baker Bros. Advisors Lp |
10 Percent Owner |
知情买入 |
50,000 |
$4.37 |
$218.25K |
7,053,176 |
| 2021-10-02 |
Moody John Roger Jr |
Chief Financial Officer |
限制性股票授予 (RSU) |
130,000 |
$6.17 |
$802.1K |
579,897 |
| 2021-10-02 |
Liu Douglas |
Chief Operating Officer |
限制性股票授予 (RSU) |
200,000 |
$6.17 |
$1.23M |
514,685 |
| 2021-10-02 |
Kelley Robert J. |
Chief Commercial Officer |
限制性股票授予 (RSU) |
130,000 |
$6.17 |
$802.1K |
427,202 |
| 2021-08-30 |
Popovits Kimberly J |
Interim CEO |
限制性股票授予 (RSU) |
550,000 |
$9.06 |
$4.98M |
550,000 |
| 2021-08-13 |
Ramakrishnan Ramesh |
Officer |
期权行权（卖出） |
8,741 |
$1.50 |
$13.11K |
- |
| 2021-05-17 |
Scott Randal W. |
Director |
知情买入 |
11,000 |
$10.11 |
$111.21K |
20,000 |
| 2021-05-14 |
Scott Randal W. |
Director |
知情买入 |
9,000 |
$10.16 |
$91.44K |
9,000 |
| 2021-03-16 |
Hilleman Jeryl L |
Director |
未知 |
- |
- |
- |
- |
| 2021-03-16 |
Hilleman Jeryl L |
Director |
限制性股票授予 (RSU) |
35,112 |
$17.60 |
$617.97K |
35,112 |
| 2021-02-17 |
Baker Bros. Advisors Lp |
10 Percent Owner |
期权行权（卖出） |
10,214,159 |
- |
- |
- |
| 2021-02-17 |
Popovits Kimberly J |
Director |
转换（卖出） |
128,655 |
- |
- |
- |
| 2021-02-17 |
Scott Randal W. |
Director |
转换（卖出） |
432,749 |
- |
- |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
